Joshua Foukas's Insider Trades & SAST Disclosures
Joshua Foukas's most recent trade in Usana Health Sciences Inc was a trade of 5,732 Common Stock done at an average price of $32.5 . Disclosure was reported to the exchange on March 12, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Joshua Foukas.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Usana Health Sciences Inc | Joshua Foukas | CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 32.54 per share. | 12 Mar 2025 | 5,732 | 0 (0%) | 0% | 32.5 | 186,514 | Common Stock |
| Usana Health Sciences Inc | Joshua Foukas | CHIEF LEGAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 26,306 | 44,887 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Joshua Foukas | CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2025 | 3,596 | 18,581 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Joshua Foukas | CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2025 | 3,596 | 7,255 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Joshua Foukas | CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2025 | 1,667 | 4,365 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Joshua Foukas | CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2025 | 1,667 | 22,177 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Joshua Foukas | CHIEF LEGAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.65 per share. | 08 Feb 2025 | 1,523 | 5,732 (0%) | 0% | 30.7 | 46,680 | Common Stock |
| Usana Health Sciences Inc | Joshua Foukas | CHIEF LEGAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.65 per share. | 08 Feb 2025 | 706 | 3,659 (0%) | 0% | 30.7 | 21,639 | Common Stock |
| Usana Health Sciences Inc | Joshua Foukas | CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 3,110 | 25,416 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Joshua Foukas | CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 3,110 | 3,110 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Joshua Foukas | CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 1,572 | 23,844 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Joshua Foukas | CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 1,572 | 3,364 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Joshua Foukas | CHIEF LEGAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 31.21 per share. | 06 Feb 2025 | 1,318 | 1,792 (0%) | 0% | 31.2 | 41,135 | Common Stock |
| Usana Health Sciences Inc | Joshua Foukas | CHIEF LEGAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.65 per share. | 06 Feb 2025 | 666 | 2,698 (0%) | 0% | 30.7 | 20,413 | Common Stock |
| Usana Health Sciences Inc | Joshua Foukas | CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 47.91 per share. | 29 Feb 2024 | 4,847 | 0 (0%) | 0% | 47.9 | 232,234 | Common Stock |
| Usana Health Sciences Inc | Joshua Foukas | CHIEF LEGAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 14,385 | 28,526 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Foukas Joshua | CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 1,667 | 5,553 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Foukas Joshua | CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 1,667 | 14,141 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Joshua Foukas | CHIEF LEGAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 50.85 per share. | 08 Feb 2024 | 706 | 4,847 (0%) | 0% | 50.8 | 35,900 | Common Stock |
| Usana Health Sciences Inc | Joshua Foukas | CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 3,111 | 17,379 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Foukas Joshua | CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 3,111 | 4,299 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Joshua Foukas | CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 1,571 | 15,808 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Joshua Foukas | CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 1,571 | 4,552 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Foukas Joshua | CHIEF LEGAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.80 per share. | 06 Feb 2024 | 1,318 | 2,981 (0%) | 0% | 47.8 | 63,000 | Common Stock |
| Usana Health Sciences Inc | Foukas Joshua | CHIEF LEGAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 49.71 per share. | 06 Feb 2024 | 666 | 3,886 (0%) | 0% | 49.7 | 33,107 | Common Stock |
| Usana Health Sciences Inc | Joshua Foukas | CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2024 | 2,188 | 2,188 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Joshua Foukas | CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2024 | 2,188 | 20,490 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Foukas Joshua | CHIEF LEGAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.23 per share. | 03 Feb 2024 | 1,000 | 1,188 (0%) | 0% | 47.2 | 47,230 | Common Stock |
| Usana Health Sciences Inc | Joshua Foukas | CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 61.01 per share. | 16 Feb 2023 | 3,771 | 0 (0%) | 0% | 61.0 | 230,069 | Common Stock |
| Usana Health Sciences Inc | Joshua Foukas | CHIEF LEGAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2023 | 12,442 | 25,918 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Joshua Foukas | CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2023 | 1,668 | 22,678 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Joshua Foukas | CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2023 | 1,668 | 4,478 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Joshua Foukas | CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2023 | 1,572 | 24,346 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Joshua Foukas | CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2023 | 1,572 | 3,476 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Joshua Foukas | CHIEF LEGAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 61.53 per share. | 06 Feb 2023 | 707 | 3,771 (0%) | 0% | 61.5 | 43,502 | Common Stock |
| Usana Health Sciences Inc | Joshua Foukas | CHIEF LEGAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 59.76 per share. | 06 Feb 2023 | 666 | 2,810 (0%) | 0% | 59.8 | 39,800 | Common Stock |
| Usana Health Sciences Inc | Joshua Foukas | CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2023 | 2,188 | 2,188 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Joshua Foukas | CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2023 | 2,188 | 14,629 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Joshua Foukas | CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2023 | 1,153 | 13,476 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Joshua Foukas | CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2023 | 1,153 | 2,393 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Joshua Foukas | CHIEF LEGAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 60.04 per share. | 03 Feb 2023 | 948 | 1,240 (0%) | 0% | 60.0 | 56,918 | Common Stock |
| Usana Health Sciences Inc | Joshua Foukas | CHIEF LEGAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 60.04 per share. | 03 Feb 2023 | 489 | 1,904 (0%) | 0% | 60.0 | 29,360 | Common Stock |
| Usana Health Sciences Inc | Joshua Foukas | CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 72.04 per share. | 16 Aug 2022 | 248 | 0 (0%) | 0% | 72.0 | 17,866 | Common Stock |
| Usana Health Sciences Inc | Joshua Foukas | CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jul 2022 | 431 | 16,817 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Joshua Foukas | CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jul 2022 | 431 | 431 (0%) | 0% | 0 | Common Stock | |
| Usana Health Sciences Inc | Joshua Foukas | CHIEF LEGAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.21 per share. | 23 Jul 2022 | 183 | 248 (0%) | 0% | 69.2 | 12,665 | Common Stock |
| Usana Health Sciences Inc | Joshua Foukas | CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 89.93 per share. | 02 Mar 2022 | 3,303 | 0 (0%) | 0% | 89.9 | 297,033 | Common Stock |
| Usana Health Sciences Inc | Joshua Foukas | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2022 | 6,286 | 18,915 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Joshua Foukas | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2022 | 1,667 | 4,009 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Joshua Foukas | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2022 | 1,667 | 17,248 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Joshua Foukas | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 94.30 per share. | 07 Feb 2022 | 706 | 3,303 (0%) | 0% | 94.3 | 66,576 | Common Stock |
| Usana Health Sciences Inc | Joshua Foukas | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2022 | 2,188 | 2,188 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Joshua Foukas | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2022 | 2,188 | 14,506 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Joshua Foukas | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2022 | 1,154 | 2,415 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Joshua Foukas | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2022 | 1,154 | 13,352 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Joshua Foukas | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 93.82 per share. | 03 Feb 2022 | 927 | 1,261 (0%) | 0% | 93.8 | 86,971 | Common Stock |
| Usana Health Sciences Inc | Joshua Foukas | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2022 | 723 | 12,629 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Joshua Foukas | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2022 | 723 | 2,649 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Joshua Foukas | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 92.32 per share. | 03 Feb 2022 | 489 | 1,926 (0%) | 0% | 92.3 | 45,144 | Common Stock |
| Usana Health Sciences Inc | Joshua Foukas | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 92.32 per share. | 03 Feb 2022 | 307 | 2,342 (0%) | 0% | 92.3 | 28,342 | Common Stock |
| Usana Health Sciences Inc | Joshua Foukas | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 95.17 per share. | 28 Oct 2021 | 181 | 0 (0%) | 0% | 95.2 | 17,226 | Common Stock |
| Usana Health Sciences Inc | Joshua Foukas | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Oct 2021 | 315 | 16,694 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Joshua Foukas | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Oct 2021 | 315 | 315 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Joshua Foukas | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 99.84 per share. | 23 Oct 2021 | 134 | 181 (0%) | 0% | 99.8 | 13,379 | Common Stock |
| Usana Health Sciences Inc | Joshua Foukas | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 97.07 per share. | 05 Aug 2021 | 249 | 0 (0%) | 0% | 97.1 | 24,170 | Common Stock |
| Usana Health Sciences Inc | Joshua Foukas | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jul 2021 | 432 | 432 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Joshua Foukas | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jul 2021 | 432 | 17,009 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Joshua Foukas | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 101.18 per share. | 23 Jul 2021 | 183 | 249 (0%) | 0% | 101.2 | 18,516 | Common Stock |
| Usana Health Sciences Inc | Joshua Foukas | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 95.02 per share. | 11 Feb 2021 | 2,906 | 0 (0%) | 0% | 95.0 | 276,128 | Common Stock |
| Usana Health Sciences Inc | Joshua Foukas | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2021 | 6,669 | 17,441 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Joshua Foukas | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2021 | 431 | 3,089 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Joshua Foukas | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2021 | 431 | 10,772 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Joshua Foukas | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 84.20 per share. | 06 Feb 2021 | 183 | 2,906 (0%) | 0% | 84.2 | 15,409 | Common Stock |
| Usana Health Sciences Inc | Joshua Foukas | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2021 | 2,188 | 13,629 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Joshua Foukas | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2021 | 2,188 | 2,188 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Joshua Foukas | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2021 | 1,153 | 12,476 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Joshua Foukas | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2021 | 1,153 | 2,414 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Joshua Foukas | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 82.76 per share. | 03 Feb 2021 | 927 | 1,261 (0%) | 0% | 82.8 | 76,719 | Common Stock |
| Usana Health Sciences Inc | Joshua Foukas | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2021 | 723 | 11,203 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Joshua Foukas | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2021 | 723 | 2,965 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Joshua Foukas | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2021 | 550 | 11,926 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Joshua Foukas | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2021 | 550 | 2,475 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Joshua Foukas | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 85.18 per share. | 03 Feb 2021 | 489 | 1,925 (0%) | 0% | 85.2 | 41,653 | Common Stock |
| Usana Health Sciences Inc | Joshua Foukas | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 84.20 per share. | 03 Feb 2021 | 307 | 2,658 (0%) | 0% | 84.2 | 25,849 | Common Stock |
| Usana Health Sciences Inc | Joshua Foukas | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 85.18 per share. | 03 Feb 2021 | 233 | 2,242 (0%) | 0% | 85.2 | 19,847 | Common Stock |
| Usana Health Sciences Inc | Joshua Foukas | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Oct 2020 | 315 | 315 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Joshua Foukas | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Oct 2020 | 315 | 15,817 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Joshua Foukas | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 84.06 per share. | 23 Oct 2020 | 197 | 0 (0%) | 0% | 84.1 | 16,560 | Common Stock |
| Usana Health Sciences Inc | Joshua Foukas | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 85.86 per share. | 23 Oct 2020 | 118 | 197 (0%) | 0% | 85.9 | 10,131 | Common Stock |
| Usana Health Sciences Inc | Joshua Foukas | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 83.15 per share. | 20 Aug 2020 | 270 | 0 (0%) | 0% | 83.2 | 22,451 | Common Stock |
| Usana Health Sciences Inc | Joshua Foukas | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jul 2020 | 431 | 431 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Joshua Foukas | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jul 2020 | 431 | 16,132 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Joshua Foukas | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 83.36 per share. | 23 Jul 2020 | 161 | 270 (0%) | 0% | 83.4 | 13,421 | Common Stock |
| Usana Health Sciences Inc | Joshua Foukas | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 82.49 per share. | 23 Apr 2020 | 1,966 | 0 (0%) | 0% | 82.5 | 162,169 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges